BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11982619)

  • 1. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha.
    Cesana C; Brando B; Boiani E; Chiodo F; Cairoli R; Intropido L; Morra E
    Eur J Haematol; 2002 Feb; 68(2):120-1. PubMed ID: 11982619
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variant hairy-cell leukemia and autoimmune hemolytic anemia].
    Galán P; Acedo MS; García Fernández JR; Martínez López J; Toscano R
    Sangre (Barc); 1996 Jun; 41(3):260-1. PubMed ID: 8755217
    [No Abstract]   [Full Text] [Related]  

  • 4. Hairy cell leukemia and autoimmune hemolytic anemia.
    Domingo A; Crespo N; Fernandez de Sevilla A; Domenech P; Jordan C; Callis M
    Leukemia; 1992 Jun; 6(6):606-7. PubMed ID: 1534859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hairy cell leukemia accompanied by Evans syndrome].
    Ebara S; Kagosima M; Marumo M; Ito Y; Tatumi E; Mitsutani S
    Rinsho Ketsueki; 2014 Apr; 55(4):466-8. PubMed ID: 24850460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
    Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemolysis of unusual antibody specificity in hairy cell leukemia.
    O'Donnell JR; Keen CM
    Br J Haematol; 1987 Apr; 65(4):499-500. PubMed ID: 3580309
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune hemolytic anemia in Philadelphia positive chronic myeloid leukemia with t(7;14) anomaly after 5 years of interferon alpha treatment.
    Köksal A; Ozatli D; Haznedaroğlu IC; Sunguroğlu A; Karakuş S; Büyükaşik Y
    Haematologia (Budap); 2002; 32(2):163-7. PubMed ID: 12412737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib.
    Ng DB; Schiller G; Ha E
    Ann Hematol; 2019 Oct; 98(10):2443-2445. PubMed ID: 31410508
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe autoimmune hemolytic anemia in hairy cell leukemia.
    Güler N; Kansu E; Türker A; Barişta I; Kanra T
    Eur J Haematol; 1997 Mar; 58(3):205-6. PubMed ID: 9150716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].
    Kötter I; Müller CA; Einsele H; Mohren M; Kanz L
    Z Rheumatol; 1999 Aug; 58(4):185-95. PubMed ID: 10502017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
    Juliusson G
    Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia.
    Laurenti L; Tarnani M; Efremov DG; Chiusolo P; De Padua L; Sica S; Leone G
    Leukemia; 2007 Aug; 21(8):1819-21; author reply 1821. PubMed ID: 17443222
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical mycobacterial infection in a patient with hairy cell leukemia.
    Trizna Z; Tschen J; Natelson EA
    Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation?].
    Giannoccaro F; Pace L; Antonaci S; Schiraldi O
    Recenti Prog Med; 1999 Nov; 90(11):592-4. PubMed ID: 10608148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
    Urosevic-Maiwald M; Nobbe S; Kerl K; Benz R
    J Dermatol; 2014 Apr; 41(4):329-33. PubMed ID: 24612373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia.
    Ilyas W; Myers D; Mann R; Seraly MP
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):316-8. PubMed ID: 10426918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumorous manifestation of hairy cell leukemia after long-term treatment with interferon alpha.
    Huhn D; Oertel J; Serke S; Kaiser D; Schmitt-Gräff A; Stein H
    Ann Hematol; 1995 Feb; 70(2):103-5. PubMed ID: 7880923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.